Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection
Sponsor: London School of Hygiene and Tropical Medicine
This observational or N/A phase trial investigates Influenza, Human and SARS-CoV-2 Infection and is currently ongoing. London School of Hygiene and Tropical Medicine leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
6 versions recorded-
May 2025 — Present [monthly]
Active Not Recruiting
Status: Unknown → Active Not Recruiting
-
Dec 2024 — May 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2022 — Jul 2024 [monthly]
Recruiting
▶ Show 1 earlier version
-
Dec 2021 — Dec 2022 [monthly]
Recruiting
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- London School of Hygiene and Tropical Medicine
- Sydney Children's Hospitals Network
- The Alfred
- The University of Queensland
- The University of Western Australia
- University of Adelaide
- University of Melbourne
- University of Newcastle, Australia
For direct contact, visit the study record on ClinicalTrials.gov .